FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162770707> ?p ?o ?g. }

• W2162770707 endingPage "1028" @default.
• W2162770707 startingPage "1013" @default.
• W2162770707 abstract "In recent years, several small molecularly-targeted kinase inhibitors have been tested in the clinic for the treatment of cancer. One category of these agents provides selective targeting of a single kinase pathway. More recently, drugs have been developed that combine molecular targets within a single type of cancer or patient. Medicinal chemistry faces the challenge of optimizing target potency and selectivity when a single agent is designed, and faces even more challenging design requirements for a single molecule with multiple targets. Since combination chemotherapy is most often required for optimal benefit, the potential benefit to combining targets in one agent is of considerable interest in drug development.A comparison was undertaken between selectively targeted tyrosine kinase inhibitors (TKI) with a single target, multiple-targeted TKI within a single pathway and TKI with an extended spectrum of targets from more than a single pathway, to determine whether multiple or extended-target TKI have greater clinical utility than selective TKI.TKI that target the epidermal growth factor receptor (EGFR) and the vascular receptors (vascular endothelial growth factor [VEGF], platelet-derived growth factor [PDGF]) were reviewed, since the number of agents available allows comparisons to be reached. Preclinical, pharmacological, pharmacodynamic and clinical data were considered.In the vascular therapeutic area, multiple-targeted TKI definitely have greater efficacy than selectively targeted agents, and there is also a trend in the EGFR area. Extended-spectrum TKI are only now in the clinic, but Phase I and early Phase II results are promising.This article discusses characteristics that candidate kinase inhibitors must possess to be acceptable for clinical use and the current state of development of several of these agents, including single-targeted kinase inhibitors, multiple-targeted single-spectrum kinase inhibitors, and extended-spectrum selective kinase inhibitors. Finally, it provides a description of challenges for the future development for this class of novel therapeutics. It appears that the greater number of targets produces a greater clinical benefit. The logistical challenges to the use of a combination of selective agents have not yet been overcome." @default.
• W2162770707 created "2016-06-24" @default.
• W2162770707 creator A5045982804 @default.
• W2162770707 creator A5064953304 @default.
• W2162770707 date "2008-06-12" @default.
• W2162770707 modified "2023-10-18" @default.
• W2162770707 title "Therapeutic potential of novel selective-spectrum kinase inhibitors in oncology" @default.
• W2162770707 cites W1539780911 @default.
• W2162770707 cites W1603230122 @default.
• W2162770707 cites W1704220988 @default.
• W2162770707 cites W1752089945 @default.
• W2162770707 cites W1971328896 @default.
• W2162770707 cites W1973019378 @default.
• W2162770707 cites W1973268287 @default.
• W2162770707 cites W1974903851 @default.
• W2162770707 cites W1975777116 @default.
• W2162770707 cites W1981247810 @default.
• W2162770707 cites W1982729445 @default.
• W2162770707 cites W1985211051 @default.
• W2162770707 cites W1985995844 @default.
• W2162770707 cites W2000894976 @default.
• W2162770707 cites W2005041472 @default.
• W2162770707 cites W2005274511 @default.
• W2162770707 cites W2005717437 @default.
• W2162770707 cites W2009042561 @default.
• W2162770707 cites W2017289276 @default.
• W2162770707 cites W2018348203 @default.
• W2162770707 cites W2024328965 @default.
• W2162770707 cites W2029231790 @default.
• W2162770707 cites W2029888054 @default.
• W2162770707 cites W2040024535 @default.
• W2162770707 cites W2045115099 @default.
• W2162770707 cites W2047654836 @default.
• W2162770707 cites W2051383707 @default.
• W2162770707 cites W2057265838 @default.
• W2162770707 cites W2059194411 @default.
• W2162770707 cites W2060490789 @default.
• W2162770707 cites W2074679486 @default.
• W2162770707 cites W2079142824 @default.
• W2162770707 cites W2089380369 @default.
• W2162770707 cites W2090699402 @default.
• W2162770707 cites W2091872802 @default.
• W2162770707 cites W2092773777 @default.
• W2162770707 cites W2097373408 @default.
• W2162770707 cites W2099259685 @default.
• W2162770707 cites W2100542906 @default.
• W2162770707 cites W2104374675 @default.
• W2162770707 cites W2105677187 @default.
• W2162770707 cites W2109678955 @default.
• W2162770707 cites W2110444464 @default.
• W2162770707 cites W2110835998 @default.
• W2162770707 cites W2111060860 @default.
• W2162770707 cites W2112940666 @default.
• W2162770707 cites W2113788015 @default.
• W2162770707 cites W2120718661 @default.
• W2162770707 cites W2123598120 @default.
• W2162770707 cites W2127101185 @default.
• W2162770707 cites W2132416188 @default.
• W2162770707 cites W2135836172 @default.
• W2162770707 cites W2138297714 @default.
• W2162770707 cites W2138449383 @default.
• W2162770707 cites W2139511378 @default.
• W2162770707 cites W2142752401 @default.
• W2162770707 cites W2143171062 @default.
• W2162770707 cites W2144503474 @default.
• W2162770707 cites W2145854263 @default.
• W2162770707 cites W2146404049 @default.
• W2162770707 cites W2147178092 @default.
• W2162770707 cites W2147289344 @default.
• W2162770707 cites W2149026055 @default.
• W2162770707 cites W2149923229 @default.
• W2162770707 cites W2151079442 @default.
• W2162770707 cites W2151566058 @default.
• W2162770707 cites W2153331460 @default.
• W2162770707 cites W2153477391 @default.
• W2162770707 cites W2154566601 @default.
• W2162770707 cites W2156394877 @default.
• W2162770707 cites W2156408558 @default.
• W2162770707 cites W2160549241 @default.
• W2162770707 cites W2162696517 @default.
• W2162770707 cites W2163124389 @default.
• W2162770707 cites W2163147844 @default.
• W2162770707 cites W2163564441 @default.
• W2162770707 cites W2165760078 @default.
• W2162770707 cites W2166271687 @default.
• W2162770707 cites W2167368130 @default.
• W2162770707 cites W2169110099 @default.
• W2162770707 cites W2169475385 @default.
• W2162770707 cites W2249043129 @default.
• W2162770707 cites W2285987216 @default.
• W2162770707 cites W2307756612 @default.
• W2162770707 cites W2537283502 @default.
• W2162770707 cites W2591385705 @default.
• W2162770707 cites W2624796964 @default.
• W2162770707 cites W2967049309 @default.
• W2162770707 cites W2980121357 @default.
• W2162770707 cites W3010327104 @default.
• W2162770707 cites W4253705647 @default.

• next